INCYTE CORPORATION Increase (Decrease) in Inventories
INCYTE CORPORATION (INCY) reported Increase (Decrease) in Inventories of $12.23 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-04-28
- INCYTE CORPORATION increase (decrease) in inventories for the quarter ending 2026-03-31 was $12.23M, a 57.21% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in inventories for the quarter ending 2025-12-31 was $4.86M, a 85.83% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in inventories for the quarter ending 2025-09-30 was $5.55M, a 33.68% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in inventories for the quarter ending 2025-06-30 was $19.52M, a 29.71% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in inventories for fiscal 2025 was $58.51M, a 54.16% decline from fiscal 2024.
- INCYTE CORPORATION increase (decrease) in inventories for fiscal 2024 was $127.63M, a 24.99% decline from fiscal 2023.
- INCYTE CORPORATION increase (decrease) in inventories for fiscal 2023 was $170.15M, a 152.06% increase from fiscal 2022.
- INCYTE CORPORATION increase (decrease) in inventories for fiscal 2022 was $67.50M, a 221.98% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-03-31 | $12.23M 10-Q · filed 2026-04-28 | $17.09M derived: sum of 2 quarters · filed 2026-04-28 | $22.64M derived: sum of 3 quarters · filed 2026-04-28 | $42.16M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $10.41M derived: sum of 2 quarters · filed 2026-02-10 | $29.94M derived: sum of 3 quarters · filed 2026-02-10 | $58.51M 10-K · filed 2026-02-10 |
| 2025-09-30 | $5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $25.08M derived: sum of 2 quarters · filed 2025-10-28 | $53.65M 10-Q · filed 2025-10-28 | $87.94M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $19.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $48.10M 10-Q · filed 2025-07-29 | $82.38M derived: sum of 3 quarters · filed 2026-04-28 | $90.76M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $28.57M 10-Q · filed 2026-04-28 | $62.85M derived: sum of 2 quarters · filed 2026-04-28 | $71.23M derived: sum of 3 quarters · filed 2026-04-28 | $99.01M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $34.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $42.66M derived: sum of 2 quarters · filed 2026-02-10 | $70.44M derived: sum of 3 quarters · filed 2026-02-10 | $127.63M 10-K · filed 2026-02-10 |
| 2024-09-30 | $8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $36.16M derived: sum of 2 quarters · filed 2025-10-28 | $93.35M 10-Q · filed 2025-10-28 | $186.31M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $27.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $84.98M 10-Q · filed 2025-07-29 | $177.93M derived: sum of 3 quarters · filed 2026-02-10 | $201.69M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $57.20M 10-Q · filed 2025-04-29 | $150.16M derived: sum of 2 quarters · filed 2026-02-10 | $173.91M derived: sum of 3 quarters · filed 2026-02-10 | $194.03M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $92.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $116.72M derived: sum of 2 quarters · filed 2026-02-10 | $136.83M derived: sum of 3 quarters · filed 2026-02-10 | $170.15M 10-K · filed 2026-02-10 |
| 2023-09-30 | $23.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $43.87M derived: sum of 2 quarters · filed 2024-10-29 | $77.19M 10-Q · filed 2024-10-29 | $96.38M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $20.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $53.44M 10-Q · filed 2024-07-30 | $72.62M derived: sum of 3 quarters · filed 2025-02-10 | $83.75M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $33.32M 10-Q · filed 2024-04-30 | $52.51M derived: sum of 2 quarters · filed 2025-02-10 | $63.63M derived: sum of 3 quarters · filed 2025-02-10 | $86.92M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $19.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $30.31M derived: sum of 2 quarters · filed 2025-02-10 | $53.60M derived: sum of 3 quarters · filed 2025-02-10 | $67.50M 10-K · filed 2025-02-10 |
| 2022-09-30 | $11.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $34.41M derived: sum of 2 quarters · filed 2023-10-31 | $48.32M 10-Q · filed 2023-10-31 | $53.07M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $23.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $37.19M 10-Q · filed 2023-08-01 | $41.94M derived: sum of 3 quarters · filed 2024-02-13 | $41.87M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $13.90M 10-Q · filed 2023-05-02 | $18.65M derived: sum of 2 quarters · filed 2024-02-13 | $18.58M derived: sum of 3 quarters · filed 2024-02-13 | $30.46M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $4.68M derived: sum of 2 quarters · filed 2024-02-13 | $16.56M derived: sum of 3 quarters · filed 2024-02-13 | $20.96M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $11.81M derived: sum of 2 quarters · filed 2022-11-01 | $16.21M 10-Q · filed 2022-11-01 | $26.48M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $11.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $16.29M 10-Q · filed 2022-08-02 | $26.55M derived: sum of 3 quarters · filed 2023-02-07 | $26.37M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $4.41M 10-Q · filed 2022-05-03 | $14.67M derived: sum of 2 quarters · filed 2023-02-07 | $14.49M derived: sum of 3 quarters · filed 2023-02-07 | $18.16M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $10.08M derived: sum of 2 quarters · filed 2023-02-07 | $13.76M derived: sum of 3 quarters · filed 2023-02-07 | $19.47M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $3.49M derived: sum of 2 quarters · filed 2021-11-02 | $9.20M 10-Q · filed 2021-11-02 | $12.39M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $9.38M 10-Q · filed 2021-08-03 | $12.57M derived: sum of 3 quarters · filed 2022-02-08 | $13.20M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $5.71M 10-Q · filed 2021-05-04 | $8.90M derived: sum of 2 quarters · filed 2022-02-08 | $9.52M derived: sum of 3 quarters · filed 2022-02-08 | $11.21M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $3.81M derived: sum of 2 quarters · filed 2022-02-08 | $5.50M derived: sum of 3 quarters · filed 2022-02-08 | $6.10M 10-K · filed 2022-02-08 |
| 2019-09-30 | $625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.31M derived: sum of 2 quarters · filed 2020-11-05 | $2.91M 10-Q · filed 2020-11-05 | $1.90M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $2.29M 10-Q · filed 2020-08-04 | $1.27M derived: sum of 3 quarters · filed 2021-02-09 | $123.00K derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-05 | -$413.00K derived: sum of 2 quarters · filed 2021-02-09 | -$1.56M derived: sum of 3 quarters · filed 2021-02-09 | -$1.56M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$2.17M derived: sum of 2 quarters · filed 2021-02-09 | -$2.16M derived: sum of 3 quarters · filed 2021-02-09 | -$4.04M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$1.15M derived: sum of 2 quarters · filed 2019-10-29 | -$3.03M 10-Q · filed 2019-10-29 | -$3.14M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$1.88M 10-Q · filed 2019-07-30 | -$1.99M derived: sum of 3 quarters · filed 2020-02-13 | -$2.27M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$1.88M 10-Q · filed 2019-04-30 | -$1.99M derived: sum of 2 quarters · filed 2020-02-13 | -$2.27M derived: sum of 3 quarters · filed 2020-02-13 | -$5.94M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$389.00K derived: sum of 2 quarters · filed 2020-02-13 | -$4.06M derived: sum of 3 quarters · filed 2020-02-13 | -$4.85M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$3.95M derived: sum of 2 quarters · filed 2018-10-30 | -$4.74M 10-Q · filed 2018-10-30 | -$4.35M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | -$3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$4.46M 10-Q · filed 2018-07-31 | -$4.07M derived: sum of 3 quarters · filed 2019-02-14 | -$6.83M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$790.00K 10-Q · filed 2018-05-01 | -$398.00K derived: sum of 2 quarters · filed 2019-02-14 | -$3.15M derived: sum of 3 quarters · filed 2019-02-14 | -$4.08M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$2.37M derived: sum of 2 quarters · filed 2019-02-14 | -$3.29M derived: sum of 3 quarters · filed 2019-02-14 | -$4.05M 10-K · filed 2019-02-14 |
| 2016-09-30 | -$2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$3.69M derived: sum of 2 quarters · filed 2017-10-31 | -$4.44M 10-Q · filed 2017-10-31 | -$5.37M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | -$930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$1.68M 10-Q · filed 2017-08-01 | -$2.61M derived: sum of 3 quarters · filed 2018-02-15 | -$2.79M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | -$752.00K 10-Q · filed 2017-05-04 | -$1.68M derived: sum of 2 quarters · filed 2018-02-15 | -$1.86M derived: sum of 3 quarters · filed 2018-02-15 | -$849.00K derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | -$928.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$1.11M derived: sum of 2 quarters · filed 2018-02-15 | -$97.00K derived: sum of 3 quarters · filed 2018-02-15 | -$98.00K 10-K · filed 2018-02-15 |
| 2015-09-30 | -$179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $831.00K derived: sum of 2 quarters · filed 2016-11-01 | $830.00K 10-Q · filed 2016-11-01 | $2.33M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.01M 10-Q · filed 2016-08-09 | $2.51M derived: sum of 3 quarters · filed 2017-02-14 | $4.58M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | -$1.00K 10-Q · filed 2016-05-09 | $1.50M derived: sum of 2 quarters · filed 2017-02-14 | $3.58M derived: sum of 3 quarters · filed 2017-02-14 | $3.59M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $3.58M derived: sum of 2 quarters · filed 2017-02-14 | $3.59M derived: sum of 3 quarters · filed 2017-02-14 | $4.09M 10-K · filed 2017-02-14 |
| 2014-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $2.08M derived: sum of 2 quarters · filed 2015-11-03 | $2.59M 10-Q · filed 2015-11-03 | $2.62M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $517.00K 10-Q · filed 2015-08-04 | $553.00K derived: sum of 3 quarters · filed 2016-02-12 | $4.32M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $506.00K 10-Q · filed 2015-04-30 | $542.00K derived: sum of 2 quarters · filed 2016-02-12 | $4.31M derived: sum of 3 quarters · filed 2016-02-12 | $6.52M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $3.80M derived: sum of 2 quarters · filed 2016-02-12 | $6.01M derived: sum of 3 quarters · filed 2016-02-12 | $6.59M 10-K · filed 2016-02-12 |
| 2013-09-30 | $3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $5.98M derived: sum of 2 quarters · filed 2014-10-30 | $6.55M 10-Q · filed 2014-10-30 | $10.10M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $2.79M 10-Q · filed 2014-07-31 | $6.33M derived: sum of 3 quarters · filed 2015-02-17 | $7.21M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $577.00K 10-Q · filed 2014-05-01 | $4.12M derived: sum of 2 quarters · filed 2015-02-17 | $5.00M derived: sum of 3 quarters · filed 2015-02-17 | $5.82M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $4.42M derived: sum of 2 quarters · filed 2015-02-17 | $5.24M derived: sum of 3 quarters · filed 2015-02-17 | $5.22M 10-K · filed 2015-02-17 |
| 2012-09-30 | $876.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.70M derived: sum of 2 quarters · filed 2013-10-31 | $1.67M 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $819.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $796.00K 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | -$23.00K 10-Q · filed 2013-05-02 | |||
| 2011-12-31 | $3.54M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |